journal article·2013-07

Strain-induced crack formations in PDMS/DXA drug collars

J.A. Warner, J.C. Polkinghorne, J. Gonerka, S. Meyer, B. Luo, C. Frethem, G. Haugstad

Acta Biomaterialia· Volume 9· Issue 7
Publisher page

Abstract

Drug-eluting systems are currently used in cardiac leads in order to reduce inflammation and fibrosis at the lead-tissue interface. Drug release from these drug delivery systems can be modulated by the manufacturing processes used to create the drug systems and assemble them onto the cardiac lead. In this study, scanning electron microscopy, atomic force microscopy and Raman microscopy are employed to explore the material characteristics of a polydimethylsiloxane-dexamethasone acetate drug collar used on cardiac leads when varying the strain during collar assembly on the lead. A novel test fixture was created in order to investigate these drug collars under simulated stresses. Measurements of the collar while fitted to a rod revealed microcracks that are hypothesized to affect the drug release performance, resulting in increased drug elution. It was found that the strain that occurs during assembly of the collar onto the lead is a key factor in the formation of these microcracks. Results also suggest that cracks tend to form in areas of high drug particle density, and propagate between drug particles.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Advanced machining processes and optimization · Diamond and Carbon-based Materials Research · Advanced Surface Polishing Techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (23)

Show source-provided references
1. Virtual electrode theory explains pacing threshold increase caused by cardiac tissue damage10.1152/ajpheart.00637.2003 ↗
2. Clinical thresholds of endocardial cardiac stimulation: a long-term study10.1016/0022-4804(75)90074-8 ↗
3. The electrode–tissue interface: the revolutionary role of steroid elution10.1111/j.1540-8159.1992.tb02905.x ↗
4. Stimulation TIMSGoLO: do steroid-eluting electrodes really have better performance than other state-of-the-art designs?10.1111/j.1540-8159.1993.tb01651.x ↗
5. The relationship between drug release rate, particle size, and swelling of silicone matrices10.1016/0168-3659(90)90088-B ↗
6. Biostability and biological performance of a PDMS-based polyurethane for controlled drug release10.1016/j.biomaterials.2008.04.007 ↗
7. Comparative study of the release kinetics of osmotically active solutes from hydrophobic elastomeric matrices combined with the characterization of the depleted matrices10.1002/app.30100 ↗
8. Nuclear magnetic imaging of an osmotic water uptake and delivery process10.1016/S0142-9612(00)00093-4 ↗
9. Controlled drug release from implantable matrices based on hydrophobic polymers10.1016/0142-9612(92)90178-Q ↗
10. The mechanical properties of the rubber elastic polymer polydimethylsiloxane for sensor applications
11. Surface energy and the contact of elastic solids
12. Accounting for the JKR–DMT transition in adhesion and friction measurements with atomic force microscopy10.1163/1568561054352685 ↗
13. Haugstad · 2012
14. Israelachvili · 2010
15. Li · 2001
16. Study of the self-adhesion hysteresis of a siloxane elastomer using the JKR method10.1021/la00019a073 ↗
17. Problems of contact angle and solid surface free energy determination10.1016/S0001-8686(01)00097-5 ↗
18. Analysis of the silica surface free energy by the imbibition technique10.1006/jcis.2001.7701 ↗
19. B. Pittenger, N. Erina, C. Su, Quantitative mechanical property mapping at the nanoscale with peakforce QNM, Veeco Application Note (2010). Available from: .
20. Gwyddion: an open-source software for SPM data analysis
21. Conservative and dissipative tip-sample interaction forces probed with dynamic AFM10.1103/PhysRevB.60.11051 ↗
22. Cross-link density estimation of PDMS networks with precise consideration of network defects10.1021/ma202030z ↗
23. Curing behavior of silicone elastomer in the presence of two corticosteroid drugs10.1002/jbm.b.32732 ↗